Form 4 Wave Life Sciences Ltd. For: Mar 23 Filed by: TAKANASHI KEN

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. MU
8. DFTX
9. HOOD
10. RGNX

Go back to Form 4 Wave Life Sciences Ltd. For: Mar 23 Filed by: TAKANASHI KEN

RBC on WAVE Life Sciences (WVE): 't we continue to see a molecule that is pharmacologically active and remain optimistic'

March 27, 2026 5:04 AM EDT

RBC Capital analyst Luca Issi reiterated an Outperform rating and $27.00 price target on WAVE Life Sciences (NASDAQ: WVE).

The analyst comments "The news: WVE reported updated INHBE data. At 240 mg, company reported 0.3/0.9% reductions in body weight (at 3/6 months), 8/14% reductions in visceral fats, 5/5% reduction in total fat and 2/2% increase in lean mass. At 400 mg, weight loss data at 3 months was not shared (we assume negligible), but WVE notes 5% reduction in visceral fats and 0.7% reduction in total fats. On lack of weight loss, WVE notes that the patients enrolled have materially... More

WAVE Life Sciences (WVE) PT Lowered to $39 at Clear Street, 'we think ‘007 should find its optimal patient population'

March 26, 2026 4:21 PM EDT

Clear Street analyst Bill Maughan lowered the price target on WAVE Life Sciences (NASDAQ: WVE) to $39.00 (from $50.00) while maintaining a Buy rating.

The analyst comments "We are updating our model to reflect peak 15% penetration into the Rx-treated US obesity market (20% Europe) (prev. 20% and... More